111 related articles for article (PubMed ID: 32741430)
21. Testing the Interpersonal-Behavior model to explain intentions to use patient-delivered partner therapy.
John SA; Walsh JL; Quinn KG; Cho YI; Weinhardt LS
PLoS One; 2020; 15(5):e0233348. PubMed ID: 32433680
[TBL] [Abstract][Full Text] [Related]
22. Acceptability and intention to seek medical care after hypothetical receipt of patient-delivered partner therapy or electronic partner notification postcards among men who have sex with men: the partner's perspective.
Kerani RP; Fleming M; Golden MR
Sex Transm Dis; 2013 Feb; 40(2):179-85. PubMed ID: 23324981
[TBL] [Abstract][Full Text] [Related]
23. Alternative approaches to partner notification, diagnosis, and treatment: perspectives of New York County Health Departments, 2007.
Davis CF; Cummings M; Coles BF; McNutt LA
Sex Transm Dis; 2009 Mar; 36(3):185-90. PubMed ID: 19174730
[TBL] [Abstract][Full Text] [Related]
24. Patient-delivered partner treatment and other partner management strategies for sexually transmitted diseases used by New York City healthcare providers.
Rogers ME; Opdyke KM; Blank S; Schillinger JA
Sex Transm Dis; 2007 Feb; 34(2):88-92. PubMed ID: 16810120
[TBL] [Abstract][Full Text] [Related]
25. Patient-delivered partner therapy in the UK: what do the professionals think?
Shivasankar S; Challenor R
Int J STD AIDS; 2008 Jul; 19(7):437-40. PubMed ID: 18574112
[TBL] [Abstract][Full Text] [Related]
26. Experiences and outcomes of partner notification among men and women recently diagnosed with Chlamydia and their views on innovative resources aimed at improving notification rates.
Bilardi JE; Fairley CK; Hopkins CA; Hocking JS; Temple-Smith MJ; Bowden FJ; Russell DB; Pitts M; Tomnay JE; Parker RM; Pavlin NL; Chen MY
Sex Transm Dis; 2010 Apr; 37(4):253-8. PubMed ID: 20182407
[TBL] [Abstract][Full Text] [Related]
27. Formative design and evaluation of patient-delivered partner therapy informational materials and packaging.
McBride K; Goldsworthy RC; Fortenberry JD
Sex Transm Infect; 2009 Apr; 85(2):150-5. PubMed ID: 19103640
[TBL] [Abstract][Full Text] [Related]
28. The Impact of Prescriptions on Sex Partner Treatment Using Expedited Partner Therapy for Chlamydia trachomatis Infection, New York City, 2014-2015.
Oliver A; Rogers M; Schillinger JA
Sex Transm Dis; 2016 Nov; 43(11):673-678. PubMed ID: 27893595
[TBL] [Abstract][Full Text] [Related]
29. High willingness to use novel HIV and bacterial sexually transmitted infection partner notification, testing, and treatment strategies among gay and bisexual men.
John SA; Starks TJ; Rendina HJ; Parsons JT; Grov C
Sex Transm Infect; 2020 May; 96(3):173-176. PubMed ID: 31189548
[TBL] [Abstract][Full Text] [Related]
30. Impact of expedited partner therapy (EPT) implementation on chlamydia incidence in the USA.
Mmeje O; Wallett S; Kolenic G; Bell J
Sex Transm Infect; 2018 Nov; 94(7):545-547. PubMed ID: 28515200
[TBL] [Abstract][Full Text] [Related]
31. Concurrent sexually transmitted infections (STIs) in sex partners of patients with selected STIs: implications for patient-delivered partner therapy.
Stekler J; Bachmann L; Brotman RM; Erbelding EJ; Lloyd LV; Rietmeijer CA; Handsfield HH; Holmes KK; Golden MR
Clin Infect Dis; 2005 Mar; 40(6):787-93. PubMed ID: 15736009
[TBL] [Abstract][Full Text] [Related]
32. A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands.
Nanhoe AC; Visser M; Omlo JJ; Watzeels AJCM; van den Broek IV; Götz HM
BMC Infect Dis; 2018 May; 18(1):243. PubMed ID: 29843643
[TBL] [Abstract][Full Text] [Related]
33. Management of Chlamydia Cases in Australia (MoCCA): protocol for a non-randomised implementation and feasibility trial.
Goller JL; Coombe J; Temple-Smith M; Bittleston H; Sanci L; Guy R; Fairley C; Regan D; Carvalho N; Simpson J; Donovan B; Tomnay J; Chen MY; Estcourt C; Roeske L; Hawkes D; Saville M; Hocking JS
BMJ Open; 2022 Dec; 12(12):e067488. PubMed ID: 36600435
[TBL] [Abstract][Full Text] [Related]
34. Patterns and determinants of patient-delivered therapy uptake among healthcare consumers.
Goldsworthy RC; Fortenberry DJ
Sex Transm Dis; 2009 Jan; 36(1):25-32. PubMed ID: 18779762
[TBL] [Abstract][Full Text] [Related]
35. Willingness of gynaecologists, doctors in family planning, GPs, practice nurses and pharmacists to adopt novel interventions for treating sexual partners of women with chlamydia.
Cameron ST; Melvin L; Glasier A; Scott G; Johnstone A; Young H
BJOG; 2007 Dec; 114(12):1516-21. PubMed ID: 17877773
[TBL] [Abstract][Full Text] [Related]
36. Patient-delivered partner therapy in the UK: what do patients think?
Shivasankar S; Challenor R; Ekanayaka R
Int J STD AIDS; 2008 Jul; 19(7):433-6. PubMed ID: 18574111
[TBL] [Abstract][Full Text] [Related]
37. It's Time to Expand Chlamydia Treatment for Gay and Bisexual Men.
Braun HM; Taylor JL
Ann Fam Med; 2021; 19(2):168-170. PubMed ID: 33685878
[TBL] [Abstract][Full Text] [Related]
38. Telling partners about chlamydia: how acceptable are the new technologies?
Hopkins CA; Temple-Smith MJ; Fairley CK; Pavlin NL; Tomnay JE; Parker RM; Bowden FJ; Russell DB; Hocking JS; Chen MY
BMC Infect Dis; 2010 Mar; 10():58. PubMed ID: 20211029
[TBL] [Abstract][Full Text] [Related]
39. The right thing to do: patients' views and experiences of telling partners about chlamydia.
Temple-Smith M; Hopkins C; Fairley C; Tomnay J; Pavlin N; Parker R; Russell D; Bowden F; Hocking J; Pitts M; Chen M
Fam Pract; 2010 Aug; 27(4):418-23. PubMed ID: 20444842
[TBL] [Abstract][Full Text] [Related]
40. Patient and partner perspectives on patient-delivered partner screening: acceptability, benefits, and barriers.
McBride KR; Goldsworthy RC; Fortenberry JD
AIDS Patient Care STDS; 2010 Oct; 24(10):631-7. PubMed ID: 20863245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
